Table 5.
Familiarity with and preferences for effective treatment among caregivers of children under five with fever in the past two weeks
Benin | DRC | Madagascar | Nigeria | Uganda | Zambia | |
---|---|---|---|---|---|---|
N = 885 | N = 2, 331 | N = 1, 970 | N = 2, 833 | N = 1, 452 | N = 1, 727 | |
% Caregivers who name the national first-line drug when asked to list anti-malarials that they have heard of | 13.5 | 3.1 | 3.5 | 6.9 | 57.2 | 81.1 |
% Caregivers who name the national first-line drug as the most effective anti-malarial for children under five | 9.8 | 2.0 | 1.8 | 4.3 | 35.1 | 49.2 |
N = 381 | N = 1, 186 | N = 965 | N = 1, 097 | N = 898 | N = 709 | |
% Children treated with an anti-malarial that received a drug requested by their caregiver | 37.5 | 35.8 | 51.9 | 21.3 | 14.1 | 7.9 |
Type of anti-malarial received, among children that received an anti-malarial requested by caregiver1 | N = 143 | N = 450 | N = 549 | N = 238 | N = 127 | N = 57 |
% Non-artemisinin monotherapy |
91.6 | 88.4 | 95.7 | 87.8 | 63.0 | 75.0 |
% ACT | 10.5 | 9.2 | 4.7 | 7.6 | 38.1 | 22.6 |
% Artemisinin monotherapy | 0.0 | 3.1 | n/a | 7.6 | 0.6 | 2.4 |
1 Categories are not mutually exclusive as some children received more than one anti-malarial